Oosthuizen Johannes Jacobus 4
4 · Merck & Co., Inc. · Filed May 2, 2024
Insider Transaction Report
Form 4
Oosthuizen Johannes Jacobus
EVP, Oncology & Int?l
Transactions
- Award
Stock Option (Right to Buy)
[F2]2024-04-30+20,508→ 20,508 totalExercise: $129.22From: 2025-04-30Exp: 2034-04-29→ Common Stock (20,508 underlying)
Holdings
- 23,358.949
Common Stock
[F1]
Footnotes (2)
- [F1]Holdings include shares acquired in dividend reinvestment transactions.
- [F2]The option vests and becomes exercisable in three equal installments on 4/30/2025, 4/30/2026 and 4/30/2027.
Signature
/s/ Kelly E. W. Grez, as attorney-in-fact for Johannes Oosthuizen|2024-05-02